Skip to Main Content

Paper Details

A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.
Biomed Pharmacother
1
2022
CYP2D6, Ondansetron, QT, QT prolongation, SLC36A1, TLR3, children, missense variant, nausea, ondansetron, patient, patients, prolonged, rs34124313, rs3775291, serotonin, women
Author NameAffiliation
Shahrad Rod RassekhBritish Columbia Children's Hospital Research Institute, Canada Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, BC Children's Hospital, University of British Columbia
Shahrad Rod RassekhBritish Columbia Children's Hospital Research Institute, Canada Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, BC Children's Hospital, University of British Columbia
Bruce C CarletonFaculty of Pharmaceutical Sciences, University of British Columbia, Canada British Columbia Children's Hospital Research Institute, Canada Pharmaceutical Outcomes Programme, British Columbia Children's Hospital
  • 1 - 3

Datasets

Release 1.2